Prescription drug · NDA
Fml (fluorometholone) NDC 11980-211
Fluorometholone 1 mg/mL · Suspension/ drops · Ophthalmic · Allergan, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 11980-211-05 | 11980021105 | 1 BOTTLE, DROPPER in 1 CARTON (11980-211-05) / 5 mL in 1 BOTTLE, DROPPERMarketed from Feb 1, 1972 | |
| 11980-211-10 | 11980021110 | 1 BOTTLE, DROPPER in 1 CARTON (11980-211-10) / 10 mL in 1 BOTTLE, DROPPERMarketed from Feb 1, 1972 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Fml
- Generic name (nonproprietary)
- fluorometholone
- Active ingredients
- Fluorometholone — 1 mg/mL
- Dosage form
- Suspension/ drops
- Route
- Ophthalmic
- Labeler
- Allergan, Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 016851
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 11980-211_000b0dad-a290-4a62-81ec-208e0a9c058bSPL ID 000b0dad-a290-4a62-81ec-208e0a9c058bSPL set ID c374d65a-35b5-4c9e-9069-5148875dc4dfRxCUI 310377, 545243UNII SV0CSG527L
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N411980021105followed by a unit qualifier and the quantityPackage 11980-0211-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE FML ® suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 016851
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Fluorometholone | Fluorometholone 1 mg/mL | Solution/ dropsOphthalmic | Pacific Pharma, Inc. | 60758-880 |